Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma (Q41718552)
Jump to navigation
Jump to search
scientific article published on 22 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma |
scientific article published on 22 May 2015 |
Statements
1 reference
Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma (English)
1 reference
Joseph H Antin
1 reference
Yi-Bin Chen
1 reference
Shuli Li
1 reference
David C Fisher
1 reference
Jessica Driscoll
1 reference
Candice Del Rio
1 reference
Jeremy Abramson
1 reference
Philippe Armand
1 reference
Jeffrey Barnes
1 reference
Jennifer Brown
1 reference
Corey Cutler
1 reference
Areej El-Jawahri
1 reference
Vincent T Ho
1 reference
Ephraim Hochberg
1 reference
Steven McAfee
1 reference
Ronald Takvorian
1 reference
Thomas R Spitzer
1 reference
Robert Soiffer
1 reference
Eric Jacobsen
1 reference
1 reference
Identifiers
1 reference